News

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year.
Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...
President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of pharmaceutical drugs in the U.S. Trump has floated 25 percent tariffs on ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.
Trump suggested that those levies would not go into effect immediately, saying he will “give people about a year, year and a half” ...
President Trump announced potential tariffs on imported pharmaceuticals by month's end, followed by semiconductor levies.
President Trump announced his intent to impose tariffs on imported pharmaceuticals and semiconductors, which may reach 200%.
The US is Australia’s biggest export market for pharmaceuticals. If the tariffs go ahead, manufacturing could suffer.
We use pharmaceutical drugs every day to heal infections, treat cancers and relieve pain. But if President Donald Trump has his way, these largely foreign-made drugs would be targeted with tariffs, ...